Can Airflow Limitation in Chronic Obstructive Pulmonary Disease (COPD) be Reversible by Drugs?

Phase 4CompletedNCT01010178

Baqiyatallah Medical Sciences University64 enrolled

Overview

Critical combination of various approved drugs in management for patients suffering with COPD.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

Macrolid, Theophylline, Inhaler CorticosteroidsDRUG

we have no permission to include them in detail because of privacy policy of mentioned journal for publication

Eligibility

Sex: ALLMin age: 22 YearsMax age: 86 Years

Medical Language ↔ Plain English

Inclusion Criteria: * current or past smoker COPD Exclusion Criteria: * history of significant occupational or other environmental exposures or a connective tissue disease

Locations (1)

Research Center of Chemical Injuries, Baqiyatallah Medical Sciences University, Mollasadra St,

Tehran, Iran

Outcomes

Primary Outcomes

15% increasing in forced expiratory volume in 1 second

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.